FDA approves new Cornell study using Intra-arterial Temodar for Glioblastoma Multiforme
Building upon the success of their trial using Intra-arterial delivery of bevacizumab (Avastin) for recurrent malignant glioma, neurosurgeons at Weill Cornell Medical College have just opened a trial for patients with newly diagnosed malignant brain tumors. Neurosurgeons, John A. Boockvar and Howard Riina, MD are testing the safety and efficacy of intra-arterial delivery of Temozolamide (Temodar) for NEWLY diagnosed malignant glioma. If you are interested in the trial please call Yair Bitton at 212-746-1996.
Contact Us
For your convenience, we offer several options for scheduling an appointment.
Request an Appointment Online.
Phone
(866) 426-7787
(212) 746-4684
Office Hours
Monday - Friday, 9:00 AM to 5:00 PM
Emergency Department,
NewYork-Presbyterian/Weill Cornell
(212) 746-5026
